Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries-Reference-Cited by-同舟云学术

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

Published:2019-05-08 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Malinowski Krzysztof Piotr,Kawalec Paweł,Trąbka Wojciech,Czech Marcin,Petrova Guenka,Manova Manoela,Savova Alexandra,Draganić Pero,Vostalová Lenka,Slabý Juraj,Männik Agnes,Márky Kristóf,Rugaja Zinta,Gulbinovic Jolanta,Tesar Tomas,Paveliu Marian Sorin

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. Bridging East with West of Europe – a comparison of orphan drugs policies in Poland, Russia and the Netherlands.;Czech;Acta Pol. Pharm. Drug Res.,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries;Frontiers in Pharmacology;2024-03-08

2. Tackling reimbursement challenges to fair access to medicines – introduction to the topic;Expert Review of Pharmacoeconomics & Outcomes Research;2023-04-17

3. COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group;Annals of Hematology;2023-02-27

4. Novel approach to decision making for orphan drugs;International Journal of Technology Assessment in Health Care;2023

5. Gene Therapy for Neuromuscular Diseases: Health Economic Challenges and Future Perspectives;Journal of Neuromuscular Diseases;2022-11-08